Profil
Hal Sternberg was the founder of Lineage Cell Therapeutics, Inc. which was founded in 1990, where he held the title of Director & Vice President-Research from 1990 to 2011.
He is currently the Vice President-Research at AgeX Therapeutics, Inc. since 2017.
Dr. Sternberg was a Research Associate at the University of California, Berkeley from 1985 to 1988.
Dr. Sternberg received his graduate degree in 1979 and his doctorate in 1982 from the University of Maryland.
Anciens postes connus de Hal Sternberg
| Sociétés | Poste | Fin |
|---|---|---|
| University of California, Berkeley | Corporate Officer/Principal | 01/01/1988 |
| AGEX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| LINEAGE CELL THERAPEUTICS, INC. | Founder | - |
Formation de Hal Sternberg
| University of Maryland | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
